These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10777616)

  • 1. Degradation of DNA topoisomerase I by a novel trypsin-like serine protease in proliferating human T lymphocytes.
    Chen HJ; Hwong CL; Wang CH; Hwang J
    J Biol Chem; 2000 Apr; 275(17):13109-17. PubMed ID: 10777616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies.
    Shimizu T; Pommier Y
    Exp Cell Res; 1996 Aug; 226(2):292-301. PubMed ID: 8806433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status.
    Mao Y; Mehl IR; Muller MT
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1235-40. PubMed ID: 11805286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase IIalpha expression.
    Salmena L; Lam V; McPherson JP; Goldenberg GJ
    Biochem Pharmacol; 2001 Apr; 61(7):795-802. PubMed ID: 11274964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The domain organization and properties of individual domains of DNA topoisomerase V, a type 1B topoisomerase with DNA repair activities.
    Belova GI; Prasad R; Nazimov IV; Wilson SH; Slesarev AI
    J Biol Chem; 2002 Feb; 277(7):4959-65. PubMed ID: 11733530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.
    Tomicic MT; Christmann M; Kaina B
    Cancer Res; 2005 Oct; 65(19):8920-6. PubMed ID: 16204064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.
    Ogiso Y; Tomida A; Lei S; Omura S; Tsuruo T
    Cancer Res; 2000 May; 60(9):2429-34. PubMed ID: 10811120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased synthesis and degradation of DNA topoisomerase I during the initial phase of human T lymphocyte proliferation.
    Hwong CL; Chen CY; Shang HF; Hwang J
    J Biol Chem; 1993 Sep; 268(25):18982-6. PubMed ID: 8395523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis.
    Kuwana M; Feghali CA; Medsger TA; Wright TM
    Arthritis Rheum; 2001 Jul; 44(7):1654-9. PubMed ID: 11465716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat stress induces hsc70/nuclear topoisomerase I complex formation in vivo: evidence for hsc70-mediated, ATP-independent reactivation in vitro.
    Ciavarra RP; Goldman C; Wen KK; Tedeschi B; Castora FJ
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1751-5. PubMed ID: 8127877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide causes Sp1 protein degradation by inducing a unique trypsin-like serine protease in rat lungs.
    Ye X; Liu SF
    Biochim Biophys Acta; 2007 Feb; 1773(2):243-53. PubMed ID: 17092579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simian virus 40 large T antigen binds to topoisomerase I.
    Simmons DT; Melendy T; Usher D; Stillman B
    Virology; 1996 Aug; 222(2):365-74. PubMed ID: 8806520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 dependence of topoisomerase I recruitment in vivo.
    Mao Y; Okada S; Chang LS; Muller MT
    Cancer Res; 2000 Aug; 60(16):4538-43. PubMed ID: 10969804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filamin (280-kDa actin-binding protein) is a caspase substrate and is also cleaved directly by the cytotoxic T lymphocyte protease granzyme B during apoptosis.
    Browne KA; Johnstone RW; Jans DA; Trapani JA
    J Biol Chem; 2000 Dec; 275(50):39262-6. PubMed ID: 11050075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of human DNA topoisomerase I and its subcellular localization in HeLa cells.
    Mo YY; Wang P; Beck WT
    Exp Cell Res; 2000 May; 256(2):480-90. PubMed ID: 10772820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases.
    Shimizu T; Pommier Y
    Leukemia; 1997 Aug; 11(8):1238-44. PubMed ID: 9264376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The domain organization of human topoisomerase I.
    Stewart L; Ireton GC; Champoux JJ
    J Biol Chem; 1996 Mar; 271(13):7602-8. PubMed ID: 8631794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and isolation of a trypsin-like serine protease from a long-term culture cytolytic T cell line and its expression by functionally distinct T cells.
    Kramer MD; Binninger L; Schirrmacher V; Moll H; Prester M; Nerz G; Simon MM
    J Immunol; 1986 Jun; 136(12):4644-51. PubMed ID: 2423597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of lysosomal cathepsins in the cleavage of DNA topoisomerase I during necrotic cell death.
    Pacheco FJ; Servin J; Dang D; Kim J; Molinaro C; Daniels T; Brown-Bryan TA; Imoto-Egami M; Casiano CA
    Arthritis Rheum; 2005 Jul; 52(7):2133-45. PubMed ID: 15986368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct autoreactive T cell responses to native and fragmented DNA topoisomerase I: influence of APC type and IL-2.
    Oriss TB; Hu PQ; Wright TM
    J Immunol; 2001 May; 166(9):5456-63. PubMed ID: 11313383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.